Deals
Blackstone Nears $1.7 Billion Deal for Summit-Backed VaxCare
This article is for subscribers only.
Blackstone Inc. is in advanced talks to acquire vaccine management company VaxCare Corp. for about $1.7 billion including debt, according to people familiar with the matter.
A deal for Summit Partners-backed VaxCare could be announced within weeks, said the people, who asked not to be identified because because the information is private. A final agreement hasn’t been reached and talks could still end without one, the people said.